Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial
Background Stereotactic ablative radiotherapy (SABR) has emerged as a new treatment
option for patients with oligometastatic disease. SABR delivers precise, high-dose …
option for patients with oligometastatic disease. SABR delivers precise, high-dose …
Age and comorbidity considerations related to radiotherapy and chemotherapy administration
G Rodrigues, M Sanatani - Seminars in radiation oncology, 2012 - Elsevier
Oncological treatment decision-making is a highly complex enterprise integrating multiple
patient, tumor, treatment, and professional factors with the available medical evidence. This …
patient, tumor, treatment, and professional factors with the available medical evidence. This …
A review of palliative radiotherapy for lung cancer and lung metastases
Introduction Treatment of thoracic symptoms related to lung cancer with palliative
radiotherapy is routinely performed in conjunction with radiation oncology practice. Various …
radiotherapy is routinely performed in conjunction with radiation oncology practice. Various …
Recent advances in palliative radiotherapy
S Lutz - Current Opinion in Supportive and Palliative Care, 2012 - journals.lww.com
The end-of-life care of cancer patients is documented to have started in the Middle Ages,
and therapeutic radiation has been used to address symptoms caused by tumors since …
and therapeutic radiation has been used to address symptoms caused by tumors since …
Future directions in palliative thoracic radiotherapy
G Rodrigues, B Movsas - Current Opinion in Supportive and …, 2012 - journals.lww.com
Future directions in palliative thoracic radiotherapy : Current Opinion in Supportive and
Palliative Care Future directions in palliative thoracic radiotherapy : Current Opinion in …
Palliative Care Future directions in palliative thoracic radiotherapy : Current Opinion in …
STUDY OF EFFICACY AND TOXICITY OF HYPOFRACTIONATED THORACIC RADIOTHERAPY 17 GRAY IN 2 FRACTIONS FOR PALLIATION IN ADVANCED NON …
Objectives: To determine the efficacy and toxicity of hypofractionated thoracic radiotherapy
17 Gray (Gy) in 2 fractions for palliation in advanced non. small-cell lung carcinoma. Study …
17 Gray (Gy) in 2 fractions for palliation in advanced non. small-cell lung carcinoma. Study …